D3 Bio presents new GTPase KRAS (G12D mutant) inhibitors

FierceBiotechPulnovo Medical scores $100M in finance round led by Medtronic

Lonza NewsLonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWS

10x Genomics BlogIs Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)? - simplywall.st

Brady CorporationMilwaukee’s Brady Corp Buying Honeywell Division - Seehafer News

FierceBiotechFoundation Medicine expands Bristol Myers Squibb collaboration with new diagnostic target

FierceBiotechIn a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer

FierceBiotechRay Therapeutics shines a light on $125M round targeting genetic eye therapy

FierceBiotechTortugas comes out of its shell with $106M to fund 4 phase 2-stage neuro drugs licensed from Asia

FierceBiotechPfizer's strategy head Andrew Baum to step down following brief tenure: reports

BioWorldPricing standoff leaves Australian patients in limbo

BioWorldMabwell turns to Hong Kong to fund ADC ambitions

BioWorldXuanzhu shares dip despite phase III ALK inhibitor data